GenFleet Therapeutics
Innovation, in Expedition
Innovation, in Expedition
Innovation, in Expedition
01 / 03

Company

GENFLEET THERAPEUTICS

As our clinical trials progress with increasing global footprint, our clinical-stage products have also received continuous recognition from our partners as we are granted with impressive payment or are entitled to co-developed late-stage products with Nasdaq-listed partners. The globalized efforts of clinical research and business development will also prepare GenFleet for a globalized strategy of commercialization in advance.

10+

Leading-edge Pipeline

80%+

R&D Staff

5

R&D Functions

60%+

Staff with Master or Doctoral Degrees

2

Manufacturing Sites

xinwenliebiaobanner-897.jpg

Science

GenFleet sets up a cutting-edge pipeline of innovative therapies with a view to our prospective and highly differentiated strategy: we basically choose biological targets or pathways that have not achieved proof of concept in clinical trials across the globe. Our proprietary and fully integrated R&D platform and diversified co-development programs promote the company's continuous innovative drug discovery and clinical progress.

0a1_06.jpg

As our clinical trials progress with increasing global footprint, our clinical-stage products have also received continuous recognition from our partners home and abroad. The globalized efforts of clinical research and business development will also prepare GenFleet for a globalized strategy of commercialization in advance.

Latest News

Careers

  • Resilience
  • Innovation
  • Empowerment
bahe2.jpg
CLL_3395_12413271-595.jpg
weixintupian_20210322181233.jpg
weixintupian_20210722094641.jpg